We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACIU icon
12401
PUT
AC Immune
ACIU
$248M
$143K ﹤0.01%
18,000
-8,800
-33% -$60.8K
ORGS
12402
DELISTED
Orgenesis Inc. Common Stock
ORGS
$143K ﹤0.01%
2,815
+1,331
+90% +$67K
SCPX
12403
DELISTED
Scorpius Holdings, Inc.
SCPX
$143K ﹤0.01%
5
-6
-55% -$163K
VNTR
12404
PUT
DELISTED
Venator Materials PLC
VNTR
$143K ﹤0.01%
30,100
-800
-3% -$3.83K
VISL
12405
CALL
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$143K ﹤0.01%
2,505
+1,190
+90% +$62.2K
AYTU icon
12406
PUT
AYTU BioPharma
AYTU
$25.5M
$142K ﹤0.01%
+1,415
New +$166K
MPU icon
12407
Mega Matrix
MPU
$14.3M
$142K ﹤0.01%
67,445
-19,115
-22% -$38.5K
WSR
12408
DELISTED
Whitestone REIT
WSR
$142K ﹤0.01%
+17,251
New +$155K
ISUN
12409
DELISTED
iSun, Inc. Common Stock
ISUN
$142K ﹤0.01%
+12,437
New +$132K
MVLAW
12410
DELISTED
Movella Holdings Inc. Warrant
MVLAW
$142K ﹤0.01%
+134,312
New +$117K
VTAQR
12411
DELISTED
Ventoux CCM Acquisition Corp. Right
VTAQR
$142K ﹤0.01%
631,624
+68,907
+12% +$14.1K
DMYQ.U
12412
DELISTED
dMY Technology Group, Inc. IV Units, each consisting of one share of Class A common stock and one-fi
DMYQ.U
$142K ﹤0.01%
14,123
-458,136
-97% -$4.64M
AXDX
12413
DELISTED
Accelerate Diagnostics
AXDX
$141K ﹤0.01%
1,755
-1,826
-51% -$145K
HITI
12414
CALL
High Tide
HITI
$206M
$141K ﹤0.01%
+17,600
New +$141K
OVID icon
12415
Ovid Therapeutics
OVID
$553M
$141K ﹤0.01%
36,113
-45,655
-56% -$180K
GRDX
12416
GridAI Technologies Corp
GRDX
$29.5M
$141K ﹤0.01%
+1
New +$108K
FGH
12417
CALL
DELISTED
FG Group Holdings Inc.
FGH
$141K ﹤0.01%
29,400
-5,700
-16% -$26.3K
CFFEU
12418
DELISTED
CF Acquisition Corp. VIII Unit
CFFEU
$141K ﹤0.01%
13,966
-846,241
-98% -$8.49M
FHS
12419
DELISTED
First High-School Education Group Co., Ltd. American Depositary Shares (each representing three (3) Class A Ordinary Shares)
FHS
$141K ﹤0.01%
+20,517
New +$138K
AONE.U
12420
DELISTED
one Units, each consisting of one Class A ordinary share, and one-fourth of a Warrant to acquire one
AONE.U
$141K ﹤0.01%
+13,430
New +$143K
APRE icon
12421
Aprea Therapeutics
APRE
$8.42M
$140K ﹤0.01%
+1,431
New +$132K
MBRX icon
12422
Moleculin Biotech
MBRX
$4.35M
$140K ﹤0.01%
101
+64
+173% +$87.3K
RAVE icon
12423
RAVE Restaurant Group
RAVE
$43.2M
$140K ﹤0.01%
94,909
+60,795
+178% +$84.2K
SABA
12424
Saba Capital Income & Opportunities Fund II
SABA
$220M
$140K ﹤0.01%
12,477
-38,974
-76% -$430K
SJT
12425
San Juan Basin Royalty Trust
SJT
$131M
$140K ﹤0.01%
27,230
+8,518
+46% +$42.7K

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.